tykhr
sign in
free sign up
Recro Pharma Inc
Drug Manufacturers-Specialty & Generic
Healthcare
REPH
51.42M shares
NASDAQ US
traded
21 Mar 2022
listed
yes
open
2.07
52 week high
3.69
high
2.14
52 week low
1.40
low
2.00
growth
-30.1%
previous Close
2.10
P/E ratio
-52
market cap
100.44M
div yield
0
usd
Dec 2021
qoq
revenue
75.36K
313.23 %
net incoming
-11.37K
-226.16 %
eps
-0.04
42.86 %
eps surprise
42.86 %
net profit margin
-15.09 %
4.00 %
operating incoming
412
22.62 %
net change in cash
1.73K
107.77 %
cash on hand
25.22K
7.35 %
cost of revenue
55.54K
322.01 %
top